When the Department of Justice decides whether to intervene in a qui tam suit filed under the False Claims Act (31 U.S.C. § 3730), that decision is the single clearest signal a defendant will get about how much exposure the case actually carries. Intervention brings the government's investigative resources, its litigation staff, and, historically, materially larger recoveries. Declination shifts the burden of prosecuting the case to the private relator, who may proceed alone while the government retains the right to reenter later, so the matter continues rather than closing. For a compliance officer reading a civil investigative demand or served with an unsealed complaint, understanding what each outcome actually means for timeline and exposure shapes the defense from day one.
The Seal Period and the Decision Point
Every qui tam complaint filed under 31 U.S.C. § 3730(b)(2) is filed in camera and remains under seal for a minimum of 60 days, with the defendant unserved and typically unaware the suit exists. During this window, the relator's disclosure statement and supporting evidence go to the government alone, which investigates through civil investigative demands, subpoenas, or coordination with agencies such as HHS-OIG or CMS. Courts routinely grant extensions for good cause, and complex healthcare billing matters regularly stay sealed well beyond the initial 60 days, sometimes for a year or more, before the government makes its election.
What Intervention Means
Under § 3730(b)(4)(A), the government may elect to proceed with the action, at which point the United States becomes the primary party and the case proceeds on DOJ's own litigation resources, typically the Civil Division's Fraud Section or the relevant U.S. Attorney's Office. Intervention adds the government's investigative and litigation capacity to a case and carries no guarantee of a plaintiff's victory. A Government Accountability Office review of qui tam litigation outcomes found that total recoveries and relator's share amounts were consistently larger in intervened cases than in declined ones, reflecting the added weight government involvement brings to settlement negotiations.
A declination reflects DOJ's resource and prioritization judgment at that point in the case, not a ruling on the strength of the allegations, and the relator may continue the action without the government as a party.
What Declination Actually Means
Under § 3730(b)(4)(B), if the government declines to proceed, it must notify the court, and the relator then has the right to conduct the action alone. Declination is frequently, and incorrectly, read by defendants as a signal the allegations lack merit, a reading the statute itself does not support. The government retains the right to be served with all pleadings and deposition transcripts at its own expense, may later intervene upon a showing of good cause under § 3730(c)(3), and can seek limited stays of discovery that would interfere with a parallel civil or criminal investigation. Declined cases can and do produce substantial recoveries, and a single large declined-case judgment can dominate an entire fiscal year's recovery total, so declination should never be treated as the end of meaningful exposure.
Reading the Signal Without Overreading It
The practical difference between the two tracks is resourcing and control, not the underlying strength of the allegations at the time of the decision. Intervened cases draw on DOJ investigative and litigation capacity and, in the aggregate, close with larger recoveries, while declined cases proceed with the relator's own counsel driving discovery and motion practice, often on a contingency-fee relator's share arrangement. The government's residual right to reenter under good cause means a declined matter is rarely closed to renewed federal interest. A defendant's exposure assessment, including reserve decisions, disclosure obligations, and settlement posture, should account for the seal-period findings the government develops and the separate, ongoing risk of a relator litigating a declined case on its own timeline.
Why Early Legal Counsel Is Critical
It is critical that healthcare providers promptly retain experienced healthcare defense counsel upon receiving a subpoena, audit notice, investigative request, or other government inquiry. Early legal intervention can protect the provider's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the provider's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the provider to unnecessary risk.
How Health Law Alliance Can Help
The practical implications for a provider's defense, disclosure obligations, and settlement strategy depend on the matter's current stage: still under seal, met with a government intervention, or declined and left to a relator to pursue. Health Law Alliance advises healthcare providers, pharmacies, and practice owners at every phase of a False Claims Act matter, including the seal period, the intervention decision, and any negotiated resolution or trial. Contact us for a free, confidential consultation to review the specifics of your matter.
